Mario Valenti
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.
Journal: Italian journal of dermatology and venereology
Published: August 24, 2026
Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).
Journal: Dermatology and therapy
Published: July 14, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.
Journal: Dermatology and therapy
Published: May 05, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: April 24, 2026
Multiple primary and familial melanoma as distinct high-risk phenotypes: a retrospective cohort study.
Journal: Frontiers in genetics
Published: April 03, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort Study.
Journal: Journal of cutaneous medicine and surgery
Published: March 17, 2026
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.
Journal: Dermatology and therapy
Published: March 04, 2026
Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings.
Journal: Dermatology and therapy
Published: February 17, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 11, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
Journal: Dermatology and therapy
Published: February 04, 2026
Dupilumab-Related Ocular Surface Disease in Atopic Dermatitis: Risk Stratification, Monitoring, and Persistence-Preserving Management.
Journal: Journal of clinical medicine
Published: January 29, 2026
Effects of tildrakizumab on circulating T cells in autoreactive psoriatic patients.
Journal: Frontiers in immunology
Published: January 24, 2026
Last Updated: 09/26/2026